DK1003774T3 - GnRH antagonister modificeret i position 5 og 6 - Google Patents

GnRH antagonister modificeret i position 5 og 6

Info

Publication number
DK1003774T3
DK1003774T3 DK98915539T DK98915539T DK1003774T3 DK 1003774 T3 DK1003774 T3 DK 1003774T3 DK 98915539 T DK98915539 T DK 98915539T DK 98915539 T DK98915539 T DK 98915539T DK 1003774 T3 DK1003774 T3 DK 1003774T3
Authority
DK
Denmark
Prior art keywords
positions
gnrh antagonists
modified
antagonists modified
gnrh
Prior art date
Application number
DK98915539T
Other languages
English (en)
Inventor
Graeme Semple
Jean E F Rivier
Guangcheng Jiang
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25273352&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1003774(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of DK1003774T3 publication Critical patent/DK1003774T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/09Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/11Gonadotropin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98915539T 1997-04-11 1998-04-13 GnRH antagonister modificeret i position 5 og 6 DK1003774T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/837,042 US5925730A (en) 1997-04-11 1997-04-11 GnRH antagonists

Publications (1)

Publication Number Publication Date
DK1003774T3 true DK1003774T3 (da) 2006-07-03

Family

ID=25273352

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98915539T DK1003774T3 (da) 1997-04-11 1998-04-13 GnRH antagonister modificeret i position 5 og 6

Country Status (37)

Country Link
US (2) US5925730A (da)
EP (1) EP1003774B1 (da)
JP (2) JP4249806B2 (da)
KR (1) KR100519421B1 (da)
CN (1) CN1230442C (da)
AR (1) AR011217A1 (da)
AT (1) ATE319736T1 (da)
AU (1) AU728642B2 (da)
BR (1) BR9808523B1 (da)
CA (1) CA2286190C (da)
CY (2) CY1108063T1 (da)
CZ (1) CZ299097B6 (da)
DE (2) DE69833751T2 (da)
DK (1) DK1003774T3 (da)
EE (1) EE03974B1 (da)
ES (1) ES2260833T3 (da)
FR (1) FR09C0028I2 (da)
HK (1) HK1025104A1 (da)
HR (1) HRP980197B1 (da)
HU (1) HU224836B1 (da)
IL (1) IL132303A0 (da)
LU (1) LU91585I2 (da)
MY (1) MY114811A (da)
NL (1) NL300395I2 (da)
NO (2) NO324991B1 (da)
NZ (1) NZ500142A (da)
PL (1) PL194509B1 (da)
PT (1) PT1003774E (da)
RU (1) RU2199549C2 (da)
SI (1) SI1003774T1 (da)
SK (1) SK285381B6 (da)
TR (1) TR199902956T2 (da)
TW (1) TW505658B (da)
UA (1) UA58547C2 (da)
UY (1) UY24958A1 (da)
WO (1) WO1998046634A1 (da)
ZA (1) ZA983062B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US5925730A (en) * 1997-04-11 1999-07-20 Ferring Bv GnRH antagonists
US5977302A (en) * 1997-11-20 1999-11-02 Ortho-Mcneil Pharmaceutical, Inc. Liquid phase process for the preparation of GnRH peptides
US8119159B2 (en) * 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US20070148228A1 (en) * 1999-02-22 2007-06-28 Merrion Research I Limited Solid oral dosage form containing an enhancer
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
GB0117057D0 (en) * 2001-07-12 2001-09-05 Ferring Bv Pharmaceutical composition
IL147138A0 (en) * 2001-12-17 2002-08-14 Yeda Res & Dev Methods of and pharmaceutical compositions for modulating cell adhesion, migration and extravasation
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
EP2322195A2 (en) 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmaceutical compositions including low dosages of desmopressin
CN101037472B (zh) * 2006-03-14 2013-03-27 中国人民解放军军事医学科学院毒物药物研究所 具有低组胺释放作用的促黄体生成素释放激素拮抗剂
EP2526950A1 (en) * 2006-04-07 2012-11-28 Merrion Research III Limited Solid oral dosage form containing an enhancer
JOP20090061B1 (ar) 2008-02-11 2021-08-17 Ferring Int Center Sa طريقة معالجة سرطان البروستاتا بمضادات الهرمونات التناسلية GnRH
KR20110007614A (ko) * 2008-05-07 2011-01-24 메리온 리서치 Ⅲ 리미티드 GnRH 관련 화합물의 조성물 및 제조 방법
TWI480286B (zh) * 2009-02-25 2015-04-11 Merrion Res Iii Ltd 雙膦酸鹽類組合物及藥物遞送
EP2421887B1 (en) * 2009-04-24 2015-04-22 Polypeptide Laboratories A/S Method for the manufacture of degarelix
CN102421414A (zh) * 2009-05-01 2012-04-18 辉凌公司 用于治疗前列腺癌的组合物
TW201043221A (en) * 2009-05-06 2010-12-16 Ferring Int Ct Sa Kit and method for preparation of a Degarelix solution
US20110039787A1 (en) 2009-07-06 2011-02-17 Ferring International Center S.A. Compositions, kits and methods for treating benign prostate hyperplasia
WO2011066386A1 (en) 2009-11-25 2011-06-03 Novetide, Ltd. Process for production of degarelix
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
WO2011120033A1 (en) * 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
EP2447276A1 (en) 2010-10-27 2012-05-02 Ferring B.V. Process for the manufacture of Degarelix and its intermediates
US9260480B2 (en) 2010-10-27 2016-02-16 Ferring B.V. Process for the manufacture of Degarelix and its intermediates
CA2822442C (en) 2010-12-22 2021-03-16 The Salk Institute For Biological Studies Cyclic crf antagonist peptides
CN103476419A (zh) 2011-01-07 2013-12-25 梅里翁第三研究有限公司 口服投药的含铁药物组合物
JO3755B1 (ar) 2011-01-26 2021-01-31 Ferring Bv تركيبات تستوستيرون
WO2013104745A1 (en) 2012-01-13 2013-07-18 Ferring Bv Pharmaceutical composition
EP2854831B1 (en) 2012-06-01 2024-07-10 Ferring B.V. Manufacture of degarelix
EP3250191B1 (en) 2015-01-29 2024-01-17 Novo Nordisk A/S Tablets comprising glp-1 agonist and enteric coating
ES2885869T3 (es) * 2015-12-17 2021-12-15 Fresenius Kabi Ipsum S R L Procedimiento para la fabricación de degarelix y sus productos intermedios
CN107778355B (zh) * 2016-08-25 2021-04-20 成都圣诺生物制药有限公司 一种合成西曲瑞克的方法
WO2019110688A1 (en) 2017-12-05 2019-06-13 Ferring B.V. A composition comprising degarelix for use in the treatment of breast cancer
CN111943960B (zh) 2019-07-29 2022-02-15 广东东阳光药业有限公司 取代的嘧啶二酮类化合物及其用途
US11332495B2 (en) 2019-09-21 2022-05-17 RK Pharma Solutions LLC Process for the preparation of Degarelix acetate and Degarelix acetate-mannitol premix
CN114456236A (zh) * 2020-11-09 2022-05-10 深圳市健翔生物制药有限公司 一种地加瑞克乙酰化杂质的制备方法
WO2023072284A1 (zh) 2021-11-01 2023-05-04 山东绿叶制药有限公司 促性腺素释放激素拮抗剂及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547370A (en) * 1983-11-29 1985-10-15 The Salk Institute For Biological Studies GnRH Antagonists
US4508921A (en) * 1984-06-28 1985-04-02 Merck & Co., Inc. Process for preparation of alpha-alkyl amino acids
US4866160A (en) * 1985-04-09 1989-09-12 The Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US5073624A (en) * 1985-04-09 1991-12-17 Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
US5171835A (en) * 1988-10-21 1992-12-15 The Administrators Of The Tulane Educational Fund LHRH antagonists
US5296468A (en) * 1989-10-30 1994-03-22 The Salk Institute For Biological Studies GnRH analogs
DE593491T1 (de) * 1991-04-25 1994-11-17 Romano S.-Cergue Deghenghi LHRH-Antagonisten.
CA2136079A1 (en) * 1992-12-18 1994-07-07 Fortuna Haviv Lhrh antagonists having modified aminoacyl residues at positions 5 and 6
IL108509A0 (en) * 1993-02-22 1994-05-30 Salk Inst For Biological Studi GnRH antagonist peptides
US5506207A (en) * 1994-03-18 1996-04-09 The Salk Institute For Biological Studies GNRH antagonists XIII
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US5925730A (en) * 1997-04-11 1999-07-20 Ferring Bv GnRH antagonists

Also Published As

Publication number Publication date
JP4249806B2 (ja) 2009-04-08
US6214798B1 (en) 2001-04-10
NL300395I1 (nl) 2009-09-01
SK139699A3 (en) 2000-11-07
CZ358699A3 (cs) 2000-06-14
ES2260833T3 (es) 2006-11-01
MY114811A (en) 2003-01-31
CN1230442C (zh) 2005-12-07
AU728642B2 (en) 2001-01-11
SI1003774T1 (sl) 2006-08-31
EP1003774B1 (en) 2006-03-08
US5925730A (en) 1999-07-20
CA2286190C (en) 2007-01-09
CZ299097B6 (cs) 2008-04-23
KR20010006233A (ko) 2001-01-26
EE03974B1 (et) 2003-02-17
UA58547C2 (uk) 2003-08-15
DE122009000033I2 (de) 2011-07-21
NO2009016I2 (no) 2014-08-25
FR09C0028I2 (fr) 2010-06-11
JP2005120101A (ja) 2005-05-12
CA2286190A1 (en) 1998-10-22
DE69833751T2 (de) 2006-11-09
ZA983062B (en) 1998-10-20
TW505658B (en) 2002-10-11
PL336213A1 (en) 2000-06-05
HK1025104A1 (en) 2000-11-03
RU2199549C2 (ru) 2003-02-27
WO1998046634A1 (en) 1998-10-22
FR09C0028I1 (da) 2009-09-25
HUP0002704A2 (hu) 2000-12-28
CY2009008I1 (el) 2012-01-25
TR199902956T2 (xx) 2000-08-21
CY2009008I2 (el) 2012-01-25
BR9808523B1 (pt) 2010-02-09
HRP980197A2 (en) 1999-02-28
CY1108063T1 (el) 2012-01-25
HRP980197B1 (en) 2002-08-31
HUP0002704A3 (en) 2003-08-28
IL132303A0 (en) 2001-03-19
JP2001523229A (ja) 2001-11-20
NL300395I2 (nl) 2010-01-04
NO994906L (no) 1999-12-13
PL194509B1 (pl) 2007-06-29
HU224836B1 (en) 2006-03-28
JP3645255B1 (ja) 2005-05-11
CN1259959A (zh) 2000-07-12
DE69833751D1 (de) 2006-05-04
AR011217A1 (es) 2000-08-02
BR9808523A (pt) 2000-05-23
NZ500142A (en) 2001-10-26
UY24958A1 (es) 2001-03-16
EE9900479A (et) 2000-06-15
LU91585I2 (fr) 2009-09-17
NO2009016I1 (no) 2009-08-10
NO994906D0 (no) 1999-10-08
PT1003774E (pt) 2006-05-31
DE122009000033I1 (de) 2009-09-17
NO324991B1 (no) 2008-01-14
SK285381B6 (sk) 2006-12-07
AU6969898A (en) 1998-11-11
ATE319736T1 (de) 2006-03-15
EP1003774A1 (en) 2000-05-31
KR100519421B1 (ko) 2005-10-06

Similar Documents

Publication Publication Date Title
DK1003774T3 (da) GnRH antagonister modificeret i position 5 og 6
DE59713038D1 (de) Streptavidinmuteine
NO2010013I2 (no) Rekombinant FSH-CTP
ID24669A (id) Turunan-turunan dolastatin 15
NO996108D0 (no) 9-oksinerytromycinderivater
NO985680D0 (no) Peptidderivater
NO20004274L (no) Proteaseaktivert reseptor 4 og anvendelse derav
DE69903961D1 (de) Muscarinagonisten und antagonisten
NO983849L (no) Peptidderivater
DE69916694D1 (de) 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
PT811593E (pt) Agentes insecticidas e acaricidas 1,4-diaril-2-fluor-2-buteno
FI972010A0 (fi) Arrangemang i en borrningsanordning
DE69834398D1 (de) Anhänger
FI974109A0 (fi) Arrangemang i en lindningsanordning
FR2764459B1 (fr) Commutateur d'impedance
FI980691A0 (fi) Xylitoltillsats i roektobak
SE9802441D0 (sv) New peptides and use thereof
SE9802562D0 (sv) New peptides and use thereof
NO972978D0 (no) Tomrock 5000
FI972291A0 (fi) Arrangemang i glasboejningsugn
FI971706A0 (fi) Traenings- och toejningsanordning
KR960003702U (ko) 펜던트 및 그를 활용한 넥타이 세트
ITRA960003U1 (it) Free movement evolution - rm 01
FR2778665B1 (fr) Polypeptide prax-1
IT237633Y1 (it) Ciondolo